Electroencephalographic and Behavioral Studies of Monomethyl Hydrazine Toxicity in the Cat
Abstract
The toxicity of monomethyl hydrazine (MMH) administered intraperitoneally in the cat was studied by reference to behavioral and neurophysiological indices. The acute lethal toxicity value (LD50) for MMH was established at 15 mg=kg, and the convulsive toxicity value (CD50) at 7m=kg. Doses of 18, 9, and 5mg=kg were then studied systematically in an effort to classify lethal, convulsive, and subconvulsive symptoms. For these doses, a preconvulsive syndrome was described involving recurrent and sustained symptoms, including vomiting, panting, rapid respiration, viscous salivation, hyperactivity, and subcortical seizure activity. The onset latency of these symptoms was directly related to dose. Several lines of evidence suggested at least a partial independence between biochemical and neurophysiological events responsible, on one hand, for convulsions and, on the other, for this preconvulsive syndrome. Convulsions were specifically delayed or prevented in animals trained to suppress movement through the use of a special EEG conditioning technique.
Published
2016-08-29
Issue
Section
HISTORICAL ARCHIVES
© International Society for Neurofeedback and Research (ISNR), all rights reserved. This article (the “Article”) may be accessed online from ISNR at no charge. The Article may be viewed online, stored in electronic or physical form, or archived for research, teaching, and private study purposes. The Article may be archived in public libraries or university libraries at the direction of said public library or university library. Any other reproduction of the Article for redistribution, sale, resale, loan, sublicensing, systematic supply, or other distribution, including both physical and electronic reproduction for such purposes, is expressly forbidden. Preparing or reproducing derivative works of this article is expressly forbidden. ISNR makes no representation or warranty as to the accuracy or completeness of any content in the Article. From 1995 to 2013 the Journal of Neurotherapy was the official publication of ISNR (www. Isnr.org); on April 27, 2016 ISNR acquired the journal from Taylor & Francis Group, LLC. In 2014, ISNR established its official open-access journal NeuroRegulation (ISSN: 2373-0587; www.neuroregulation.org).